PHR Q1 2027 Earnings Call Summary | Stock Taper
Logo
PHR

PHR — Phreesia, Inc.

NYSE


Q1 2027 Earnings Call Summary

May 27, 2026

Summary of Phreesia Q1 2027 Earnings Call

1. Key Financial Results and Metrics

  • Revenue: $130.9 million, up 13% year-over-year.
  • Adjusted EBITDA: $30.5 million, compared to $20.8 million in Q1 2026, representing a margin of 23%.
  • Net Income: $3 million, reversing from a net loss of $3.9 million in the prior year.
  • Average Healthcare Services Clients (AHSC): 4,700, up 7% year-over-year.
  • Total Revenue per AHSC: $27,811, a 6% increase year-over-year.
  • Total Managed Payments: $1.786 billion, with a Payment Solutions revenue rate of 2.3%.
  • Free Cash Flow: $16.4 million, an improvement of $8.9 million year-over-year.
  • Cash Position: $76.4 million in cash and equivalents, up from $73.8 million at the end of January 2026.

2. Strategic Updates and Business Highlights

  • Growth Drivers: Strong performance in Payment Solutions (40% growth) and Network Solutions (15% growth).
  • Access One Integration: Continued focus on expanding Access One's financing solutions and integrating it into the company's offerings.
  • AI Initiatives: Emphasis on leveraging AI to enhance operational efficiency and client engagement.
  • Restructuring Plan: Implemented in May 2026 to reduce operating expenses and align costs with business priorities, expected to yield significant annual savings.

3. Forward Guidance and Outlook

  • Revenue Outlook for FY 2027: Maintained at $510 million to $520 million, including approximately $37 million from Access One.
  • Adjusted EBITDA Outlook: Expected to be in the range of $125 million to $135 million.
  • AHSC Growth: Anticipated mid-single-digit percentage growth.
  • Total Revenue per AHSC: Expected to grow in the low single-digit percentage range.

4. Bad News, Challenges, or Points of Concern

  • Network Solutions Spending: Clients are committing lower spend levels for the second half of FY 2027, influenced by brand-specific dynamics and regulatory policies, leading to increased variability in revenue forecasting.
  • Subscription Revenue Decline: Experienced a 6% sequential decline in subscription revenue, raising concerns about future growth in this segment.
  • Market Dynamics: Some uncertainty regarding the demand environment and potential impacts on revenue from regulatory changes.

5. Notable Q&A Insights

  • Access One Expansion: The new agreement with PNC Bank allows for greater capacity and the ability to serve non-investment-grade clients, which could enhance cash flow for healthcare providers.
  • Sales and Marketing Strategy: The shift from subscription to payments and network solutions is prompting changes in sales strategies, focusing on product-led growth and monetization.
  • Network Solutions Performance: The newly launched Provider Connect product is gaining traction, but there remains caution regarding overall spending in the second half of the fiscal year.
  • Voice AI and Clinical Integrations: Ongoing investments in clinical integrations and voice AI are seen as critical for enhancing provider engagement and addressing market needs.

This summary encapsulates the key aspects of Phreesia's Q1 2027 earnings call, highlighting both the positive developments and the challenges the company faces moving forward.